Roundtable Discussion: Drug Substance Process Development for Biologics

Time: 3:00 pm
day: Stream 2 - Day 1 PM


• Which continuous processing technology would you consider as the most value-added? Why?
• What is your organization’s goal for adopting continuous processing? Single Step, leveraging useful technologies, or end-to-end approach?
• What is your organization’s decision making process on which technology should be adopted? Which functions are involved? What are the factors considered (Cost, time, production sites, etc.)?
• What effort or initiative would you like to see in biologics space to facilitate implementation of continuous processing?
• By comparing with Small Molecule production, what would you consider as challenges for implementing continuous processing on biologics production?